Okapi Medical this week appointed Darren Obrigkeit as CEO and announced the successful pre-clinical study of the company’s wound closure technology. Obrigkeit has more than 20 years of experience in the medical device industry and has held leadership roles internationally for startups and large companies. “I’m thrilled to join the Okapi team,” Obrigkeit said in […]
Mayo Clinic, W.L. Gore team up on stem cell therapy treatments
Mayo Clinic and W. L. Gore & Associates have announced a partnership to develop implantable cell therapies to treat debilitating conditions with no cure. The for-profit company, Avobis Bio, will combine a patient’s own stem cells with bioabsorbable scaffolds to stimulate the healing of perianal fistulas, painful tunneling wounds that affect patients with Crohn’s disease. […]
MolecuLight wins FDA clearance for handheld imaging device
MolecuLight announced that it won FDA 510(k) clearance for its i:X handheld fluorescence imaging device for detecting wounds containing bacteria. MolecuLight i:X is designed to enable real-time point-of-care visualization of fluorescence in wounds, while it measures wounds and digitally records images and measurements. It received FDA de novo clearance in August 2018. The device’s fluorescence […]
Baxter spending $350m to acquire surgical adhesion barrier tech from Sanofi
Baxter (NYSE:BAX) said today that it will buy the Seprafilm adhesion barrier and related assets from Sanofi (NYSE:SNY) in what is expected to be a $350 million deal. The purchase is expected to close no later than the first quarter of 2020. A Bloomberg report in October hinted that a deal might be in the work. “While […]
8 execs exit Acelity after 3M takeover
Eight top executives have departed wound care giant Acelity following its recent $6.7 billion purchase by 3M (NYSE:MMM), according to a report in the San Antonio Express-News. The executives include Acelity CEO Andrew Eckert, president & COO Gaurav Agarwal, CFO Tracy Jokinen, general counsel John Bibb, international president Ramesh Subrahmanian and Rohit Kashyap, president of global […]
5 ways medtech research aims to help veterans
As the United States prepares to honor its military veterans on Monday, medtech researchers are working to help survivors wounded in battle, both in body and mind. Whether the research comes out of government, industry or academia, there’s also a desire to help veterans facing other health challenges. Get the full story on our sister […]
Smith & Nephew beats on Q3 sales, raises outlook
Smith & Nephew (NYSE:SNN) today reported third-quarter revenues that beat the consensus forecast and raised its outlook on the rest of the year. The London-based orthopedics and wound care giant posted sales growth of 6.6% to $1.25 billion for the three months ended Sept. 28, compared with Q3 2018. Analysts were looking for sales of […]
Sanara MedTech closes $10m equity offering
Sanara MedTech said last week that it closed a private equity offering worth $10 million in common stock. The offering included more than 1.2 million newly issued shares at $8.30 each, according to Forth Worth, Texas-based Sanara, formerly known as Wound Management Technologies. They were sold to three unnamed investors, according to a regulatory filing. […]
Smith & Nephew taps ex-Roche chief Diggelman for CEO | Personnel Moves, October 21, 2019
Smith & Nephew (NYSE:SNN) today named former Roche (PINK:RHHBY) chief Roland Diggelmann to replace Namal Nawana next month. Nawana, named to succeed Olivier Bohuon last year, is stepping down effective Nov. 1 “to pursue other opportunities outside of the U.K.,” the London-based healthcare giant said. Nawana is slated to stay on until Dec. 31 to […]
Report: Sanofi is shopping SepraFilm unit to Baxter
Sanofi (NYSE:SNY) is said to be in advanced talks with BAX to sell its Seprafilm surgical products business for up to $400 million. SepraFilm is designed to prevent adhesion after abdominal surgeries. The French drugmaker, which acquired SepraFilm in 2011 when it paid $20.1 billion for Genzyme, wants to close the deal “with the next few […]
Admedus deals biologic patch business to LeMaitre Vascular for $24m
Admedus (ASX:AHZ) dealt its biologic patch business to LeMaitre Vascular (NSDQ:LMAT) in a deal worth up to $24.6 million to focus on the transcatheter aortic valve replacement market. The A$36.2 million buyout of the CardioCel and VascuCel patches called for LeMaitre to put up $14.2 million up front, with another $1.4 million due in a pair […]
- 1
- 2
- 3
- …
- 20
- Next Page »
MassDevice Network
@MassDevice
LinkedIn
YouTube